Matthew Ros
2016
In 2016, Matthew Ros earned a total compensation of $1.5M as Chief Strategy and Business Officer at Epizyme.
Compensation breakdown
| Bonus | $65,000 |
|---|---|
| Non-Equity Incentive Plan | $86,864 |
| Option Awards | $1,128,422 |
| Salary | $237,500 |
| Other | $2,837 |
| Total | $1,520,623 |
Ros received $1.1M in option awards, accounting for 74% of the total pay in 2016.
Ros also received $65K in bonus, $86.9K in non-equity incentive plan, $237.5K in salary and $2.8K in other compensation.
Rankings
In 2016, Matthew Ros' compensation ranked 6,192nd out of 14,075 executives tracked by ExecPay. In other words, Ros earned more than 56.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,192 out of 14,075 | 56th |
Division Manufacturing | 2,272 out of 5,489 | 59th |
Major group Chemicals And Allied Products | 747 out of 1,895 | 61st |
Industry group Drugs | 566 out of 1,538 | 63rd |
Industry Pharmaceutical Preparations | 444 out of 1,176 | 62nd |
Source: SEC filing on April 18, 2019.
Ros' colleagues
We found four more compensation records of executives who worked with Matthew Ros at Epizyme in 2016.